Proteus mirabilis resistant to expanded-spectrum cephalsoporins (ESC) is an emerging problem. In addition to extended-sectrum -lactamases (ESBLs), acquired AmpC-type -lactamases represent an important mechanism of resistance to ESC in P. mirabilis, at least in some countries. Distinction of clinical isolates producing an ESBL or an AmpC-type enzyme is a matter of interest for the implications in surveillance, infection control, and treatment issues. This work describes a simple and practical Double Synergy Differential Test (DSDT) that couples the detection of ESBLs and AmpC-type enzymes by means of a combo-disk approach using cefotaxime and ceftazidime as indicator substrates, and clavulanate and boronic acid as enzyme inhibitors. The DSDT was tested with a collection of 104 P. mirabilis with different beta-lactamase profiles, and proved to be highly sensitive and specific for the detection of ESBL- and AmpC-producing isolates.

Double Synergy Differential Test for detection of plasmid-mediated AmpC-type beta-lactamases in Proteus mirabilis / Sabia, Carla; M., Sarti; E., Mantengoli; R., Gargiulo; C., Mugnaioli; G. M., Rossolini. - In: JOURNAL OF MEDICAL MICROBIOLOGY. - ISSN 0022-2615. - ELETTRONICO. - 59:8(2010), pp. 998-1000. [10.1099/jmm.0.020180-0]

Double Synergy Differential Test for detection of plasmid-mediated AmpC-type beta-lactamases in Proteus mirabilis.

SABIA, Carla;
2010

Abstract

Proteus mirabilis resistant to expanded-spectrum cephalsoporins (ESC) is an emerging problem. In addition to extended-sectrum -lactamases (ESBLs), acquired AmpC-type -lactamases represent an important mechanism of resistance to ESC in P. mirabilis, at least in some countries. Distinction of clinical isolates producing an ESBL or an AmpC-type enzyme is a matter of interest for the implications in surveillance, infection control, and treatment issues. This work describes a simple and practical Double Synergy Differential Test (DSDT) that couples the detection of ESBLs and AmpC-type enzymes by means of a combo-disk approach using cefotaxime and ceftazidime as indicator substrates, and clavulanate and boronic acid as enzyme inhibitors. The DSDT was tested with a collection of 104 P. mirabilis with different beta-lactamase profiles, and proved to be highly sensitive and specific for the detection of ESBL- and AmpC-producing isolates.
2010
59
8
998
1000
Double Synergy Differential Test for detection of plasmid-mediated AmpC-type beta-lactamases in Proteus mirabilis / Sabia, Carla; M., Sarti; E., Mantengoli; R., Gargiulo; C., Mugnaioli; G. M., Rossolini. - In: JOURNAL OF MEDICAL MICROBIOLOGY. - ISSN 0022-2615. - ELETTRONICO. - 59:8(2010), pp. 998-1000. [10.1099/jmm.0.020180-0]
Sabia, Carla; M., Sarti; E., Mantengoli; R., Gargiulo; C., Mugnaioli; G. M., Rossolini
File in questo prodotto:
File Dimensione Formato  
998.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 76.97 kB
Formato Adobe PDF
76.97 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/648958
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 3
social impact